Samuels Louis E, Casanova-Ghosh Elena, Rodriguez Roberto, Droogan Christopher
Department of Surgery, Division of Cardiothoracic Surgery, Lankenau Medical Center, Wynnewood, PA, USA.
J Cardiothorac Surg. 2012 Mar 12;7:21. doi: 10.1186/1749-8090-7-21.
Left Ventricular Assist Device (LVAD) for Destination Therapy (DT) is an established therapy for end stage heart failure patients who are not transplant candidates. Many DT patients requiring LVADs have had prior open heart surgery, the majority of whom had prior sternotomy. In addition, DT patients tend to be older and more likely to have more significant co-morbidities than their Bridge-To-Transplant (BTT) counterparts. As such, placement of an implantable LVAD in DT patients can be technically hazardous and potentially prone to more perioperative complications. The purpose of this report is to describe an alternative implantation approach for the implantation of the Heartmate II™ LVAD in high risk DT patients.
用于终末期心力衰竭患者（非移植候选者）的左心室辅助装置（LVAD）进行目标治疗（DT）是一种既定的治疗方法。许多需要LVAD的DT患者曾接受过心脏直视手术，其中大多数人曾接受过胸骨切开术。此外，与“过渡到移植”（BTT）的患者相比，DT患者往往年龄更大，合并症更严重。因此，在DT患者中植入可植入式LVAD在技术上可能具有危险性，并且可能更容易出现更多围手术期并发症。本报告的目的是描述一种在高风险DT患者中植入Heartmate II™ LVAD的替代植入方法。
